Related Experiment Videos
Disrupting sensitization of TRPV4
Konrad Mack1, Michael J M Fischer2
1Institute of Physiology and Pathophysiology, University of Erlangen-Nuremberg, Germany.
Neuroscience
|April 5, 2017
Summary
Targeting the interaction between TRPV4 channels and AKAP79 offers a novel approach to control pain. A specific peptide reduced TRPV4 sensitization, validating this strategy for managing heightened pain responses.
Area of Science:
- Molecular Biology
- Neuroscience
- Pharmacology
Background:
- Transient Receptor Potential Vanilloid 4 (TRPV4) ion channels are implicated in inflammatory pain.
- Directly blocking TRPV4 may disrupt normal physiological functions.
- Targeting protein interactions, like with A-kinase anchoring protein 79 (AKAP79), is a potential therapeutic strategy.
Purpose of the Study:
- To investigate the interaction between TRPV4 and AKAP79.
- To explore the potential of modulating this interaction to control TRPV4 activity and associated pain sensitization.
Main Methods:
- Utilized HEK293t cells expressing AKAP79.
- Employed trypsin and a protease-activated receptor 2 agonist to study TRPV4 activation.
- Tested an AKAP inhibitor peptide (Ht31) and a synthetic peptide (771-781::TAT) targeting the TRPV4-AKAP79 interaction.
Main Results:
- AKAP79 expression alone did not sensitize TRPV4.
- Protease activation facilitated TRPV4 responses.
- The AKAP inhibitor peptide Ht31 inhibited TRPV4 activation.
- The synthetic 771-781::TAT peptide significantly reduced TRPV4 sensitization, unlike a control peptide.
Conclusions:
- The interaction between TRPV4 and AKAP79 plays a role in TRPV4 channel activity.
- Targeting the TRPV4-AKAP79 interaction with specific peptides is a viable strategy to control TRPV4-mediated pain sensitization.